Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 3
2014 3
2015 4
2016 4
2017 7
2018 4
2019 2
2020 1
2021 6
2022 4
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial.
Ostuzzi G, Gastaldon C, Tettamanti M, Cartabia M, Monti I, Aguglia A, Aguglia E, Bartoli F, Callegari C, Canozzi A, Carbone EA, Carrà G, Caruso R, Cavallotti S, Chiappini S, Colasante F, Compri B, D'Agostino A, De Fazio P, de Filippis R, Gari M, Ielmini M, Ingrosso G, Mammarella S, Martinotti G, Rodolico A, Roncone R, Sterzi E, Tarsitani L, Tiberto E, Todini L, Amaddeo F, D'Avanzo B; VESPA Study Group; Barbato A, Barbui C. Ostuzzi G, et al. Among authors: cartabia m. EClinicalMedicine. 2024 Feb 15;69:102491. doi: 10.1016/j.eclinm.2024.102491. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38384338 Free PMC article.
Drug prescription profile in children with autism spectrum disorders.
Clavenna A, Cartabia M, Fortino I, Bonati M. Clavenna A, et al. Among authors: cartabia m. Eur J Clin Pharmacol. 2024 Feb;80(2):297-299. doi: 10.1007/s00228-023-03610-4. Epub 2023 Dec 20. Eur J Clin Pharmacol. 2024. PMID: 38117333 No abstract available.
UDCA treatment against COVID-19: Do we have enough clinical evidence for drug repurposing?
Ojeda-Fernández L, Baviera M, Macaluso G, Schena S, Tettamanti M, Cartabia M, Foresta A, Manucci PM, Nobili A, Remuzzi G, Roncaglioni C. Ojeda-Fernández L, et al. Among authors: cartabia m. J Intern Med. 2024 Jan;295(1):110-112. doi: 10.1111/joim.13711. Epub 2023 Aug 22. J Intern Med. 2024. PMID: 37592407 No abstract available.
42 results